Francesca Rancati

Statistics

Publications

Citations

298

H-Index

Active since

2001

Affiliations

IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola(Current)

University of Bologna

Francesca Rancati is an author at IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola specializing in medicine, hematology, and molecular oncology.

Publications per year

2001–2010

Publications

The efficacy of imatinib mesylate in patients with FIP1L1-PDGFR -positive hypereosinophilic syndrome. Results of a multicenter prospective study

Michele Baccarani, Daniela Cilloni, Michela Rondoni et al. · Haematologica · 2007 · 195 citations · Full text

Medicine, Hematology, Pharmacotherapy +13

Rapamycin increases the cellular concentration of the BCL-2 protein and exerts an anti-apoptotic effect

Angela Calastretti, Francesca Rancati, Michela Ceriani et al. · European Journal of Cancer · 2001 · 42 citations

Life Sciences, Cell Biology, Pharmacology +16

High-dose imatinib improves cytogenetic and molecular remissions in patients with pretreated Philadelphia-positive, BCR-ABL-positive chronic phase chronic myeloid leukemia: first results from the randomized CELSG phase III CML 11 "ISTAHIT" study

Andreas Petzer, Dominik Wolf‎, Dominic Fong et al. · Haematologica · 2010 · 31 citations · Full text

Medicine, Hematology, Pharmacotherapy +14

Imatinib mesylate in the treatment of newly diagnosed or refractory/resistant c-KIT positive acute myeloid leukemia. Results of an italian multicentric phase II study.

Pier Paolo Piccaluga, Michele Malagola, Michela Rondoni et al. · Haematologica · 2007 · 18 citations · Full text

Medicine, Hematology, Pharmacology +13

Glivec and CML: a lucky date.

Giuseppe Saglio, D. Cilloni, Francesca Rancati et al. · PubMed · 2005 · 12 citations

Life Sciences, Molecular Biology, Oncology +17

1–5 of 5